Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes

Journal of Angiogenesis Research

Volumn 2, Issue 1, 2010, Pages

  Govani, Fatima S ^a   Shovlin, Claire L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SPROUTY PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ARTICLE; CENTROMERE; CHROMOSOME 5; GENE; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC RECOMBINATION; HAPLOTYPE; HHT3 GENE; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 77955854944     PISSN: None     EISSN: 20402384     Source Type: Journal    
DOI: 10.1186/2040-2384-2-15     Document Type: Article

References (55)

1. The logic of TGFbeta signaling. J Massague RR Gomis, FEBS Lett 2006 580 12 2811 2820 10.1016/j.febslet.2006.04.033 16678165
2. Specificity, diversity, and regulation in TGF-beta superfamily signaling. E Piek CH Heldin P Ten Dijke, FASEB J 1999 13 15 2105 2124 10593858
3. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. AC Daly RA Randall CS Hill, Mol Cell Biol 2008 28 22 6889 6902 10.1128/MCB.01192-08 18794361
4. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. SO Park YJ Lee T Seki KH Hong N Fliess Z Jiang A Park X Wu V Kaartinen BL Roman SP Oh, Blood 2008 111 2 633 642 10.1182/blood-2007-08-107359 17911384
5. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. PD Upton RJ Davies RC Trembath NW Morrell, J Biol Chem 2009 284 23 15794 15804 10.1074/jbc.M109.002881 19366699
6. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. MJ Goumans G Valdimarsdottir S Itoh F Lebrin J Larsson C Mummery S Karlsson P ten Dijke, Mol Cell 2003 12 4 817 828 10.1016/S1097-2765(03)00386-1 14580334
7. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. SP Oh T Seki KA Goss T Imamura Y Yi PK Donahoe L Li K Miyazono P ten Dijke S Kim E Li, Proc Natl Acad Sci USA 2000 97 6 2626 2631 10.1073/pnas.97.6.2626 10716993
8. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. N Pece-Barbara S Vera K Kathirkamathamby S Liebner GM Di Guglielmo E Dejana JL Wrana M Letarte, J Biol Chem 2005 280 30 27800 27808 10.1074/jbc.M503471200 15923183
9. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. FS Govani CL Shovlin, Eur J Hum Genet 2009 17 7 860 871 10.1038/ejhg.2009.35 19337313
10. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. KA McAllister KM Grogg DW Johnson CJ Gallione MA Baldwin CE Jackson EA Helmbold DS Markel WC McKinnon J Murrell MK McCormick MA Pericak-Vance P Heutink BA Oostra T Haitjema CJJ Westermann ME Porteous AE Guttmacher M Letarte DA Marchuk, Nat Genet 1994 8 4 345 351 10.1038/ng1294-345 7894484
11. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. DW Johnson JN Berg MA Baldwin CJ Gallione I Marondel SJ Yoon TT Stenzel M Speer MA Pericak-Vance A Diamond AE Guttmacher CE Jackson L Attisano R Kucherlapati ME Porteous DA Marchuk, Nat Genet 1996 13 2 189 195 10.1038/ng0696-189 8640225
12. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). CJ Gallione GM Repetto E Legius AK Rustgi SL Schelley S Tejpar G Mitchell Drouin CJJ Westermann DA Marchuk, The Lancet 2004 363 9412 852 859 10.1016/S0140-6736(04)15732-2 (Pubitemid 38368834)
13. Endoglin in angiogenesis and vascular diseases. P ten Dijke MJ Goumans E Pardali, Angiogenesis 2008 11 1 79 89 10.1007/s10456-008-9101-9 18283546
14. Emerging role of bone morphogenetic proteins in angiogenesis. L David JJ Feige S Bailly, Cytokine Growth Factor Rev 2009 20 3 203 212 10.1016/j.cytogfr.2009.05.001 19502096
15. Diagnostic Criteria for Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome). CL Shovlin AE Guttmacher E Buscarini ME Faughnan RH Hyland CJJ Westermann AD Kjeldsen H Plauchu, American Journal of Medical Genetics 2000 91 1 66 67 10.1002/(SICI)1096-8628(20000306)91:1<66::AID- AJMG12>3.0.CO;2-P 10751092
16. A murine model of hereditary hemorrhagic telangiectasia. A Bourdeau DJ Dumont M Letarte, J Clin Invest 1999 104 10 1343 1351 10.1172/JCI8088 10562296
17. Defective angiogenesis in mice lacking endoglin. DY Li LK Sorensen BS Brooke LD Urness EC Davis DG Taylor BB Boak DP Wendel, Science 1999 284 5419 1534 1537 10.1126/science.284.5419.1534 10348742
18. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. HM Arthur J Ure AJ Smith G Renforth DI Wilson E Torsney R Charlton DV Parums T Jowett DA Marchuk J Burn AG Diamond, Dev Biol 2000 217 1 42 53 10.1006/dbio.1999.9534 10625534
19. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. LD Urness LK Sorensen DY Li, Nat Genet 2000 26 3 328 331 10.1038/81634 11062473
20. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. S Srinivasan MA Hanes T Dickens ME Porteous SP Oh LP Hale DA Marchuk, Hum Mol Genet 2003 12 5 473 482 10.1093/hmg/ddg050 12588795
21. Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. BL Roman VN Pham ND Lawson M Kulik S Childs AC Lekven DM Garrity RT Moon MC Fishman RJ Lechleider BM Weinstein, Development 2002 129 12 3009 3019 12050147
22. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. SO Park M Wankhede YJ Lee EJ Choi N Fliess SW Choe SH Oh G Walter MK Raizada BS Sorg SP Oh, J Clin Invest 2009 119 11 3487 3496 19805914
23. Pathogenesis of arteriovenous malformations in the absence of endoglin. M Mahmoud KR Allinson Z Zhai R Oakenfull P Ghandi RH Adams M Fruttiger HM Arthur, Circ Res 2010 106 8 1425 1433 10.1161/CIRCRESAHA.109.211037 20224041
24. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. A Mitchell LA Adams G MacQuillan J Tibballs R vanden Driesen L Delriviere, Liver Transpl 2008 14 2 210 213 10.1002/lt.21417 18236396
25. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. F Lebrin S Srun K Raymond S Martin S van den Brink C Freitas C Breant T Mathivet B Larrivee JL Thomas HM Arthur CJ Westermann F Disch JJ Mager RJ Snijder A Eichmann CL Mummery, Nat Med 2010 16 4 420 428 10.1038/nm.2131 20364125
26. Hereditary haemorrhagic telangiectasia: Pathogenesis, diagnosis and treatment. CL Shovlin, Blood Reviews 2010
27. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. Y Sato DB Rifkin, J Cell Biol 1989 109 1 309 315 10.1083/jcb.109.1.309 2526131
28. Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis. ML Mancini A Terzic BA Conley LH Oxburgh T Nicola CP Vary, Dev Dyn 2009 238 10 2479 2493 10.1002/dvdy.22066 19705428
29. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice. RL Carvalho F Itoh MJ Goumans F Lebrin M Kato S Takahashi M Ema S Itoh M van Rooijen P Bertolino P Ten Dijke CL Mummery, J Cell Sci 2007 120 Pt 24 4269 4277 10.1242/jcs.013169 18029401
30. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1. M Letarte ML McDonald C Li K Kathirkamathamby S Vera N Pece-Barbara S Kumar, Cardiovasc Res 2005 68 1 155 164 10.1016/j.cardiores.2005.04.028 15907823
31. Update on molecular diagnosis of hereditary hemorrhagic telangiectasia. J Richards-Yutz K Grant EC Chao SE Walther A Ganguly, Hum Genet 2010 128 1 61 77 10.1007/s00439-010-0825-4 20414677
32. Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model. P Bayrak-Toydemir J McDonald R Mao A Phansalkar F Gedge J Robles D Goldgar E Lyon, Exp Mol Pathol 2008 85 1 45 49 10.1016/j.yexmp.2008.03.006 18495117
33. Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation. J McDonald F Gedge A Burdette J Carlisle CJ Bukjiok M Fox P Bayrak-Toydemir, J Mol Diagn 2009 11 6 569 575 10.2353/jmoldx.2009.080148 19767588
34. Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. C Gallione AS Aylsworth J Beis T Berk B Bernhardt RD Clark C Clericuzio C Danesino J Drautz J Fahl Z Fan ME Faughnan A Ganguly J Garvie K Henderson U Kini T Leedom M Ludman A Lux M Maisenbacher S Mazzucco C Olivieri JK Ploos van Amstel N Prigoda-Lee RE Pyeritz W Reardon K Vandezande JD Waldman RI White CA Williams DA Marchuk, Am J Med Genet A 2010 152A 2 333 339 10.1002/ajmg.a.33206 20101697
35. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. SG Cole ME Begbie GMF Wallace CL Shovlin, Journal of Medical Genetics 2005 42 577 582 10.1136/jmg.2004.028712 15994879
36. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. P Bayrak-Toydemir J McDonald N Akarsu RM Toydemir F Calderon T Tuncali W Tang F Miller R Mao, Am J Med Genet A 2006 140 20 2155 2162 16969873
37. FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis. S Hayrabedyan S Kyurkchiev I Kehayov, J Reprod Immunol 2005 67 1-2 87 101 10.1016/j.jri.2005.07.001 16165218
38. Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. RE Mayer P Hendrix P Cron R Matthies SR Stone J Goris W Merlevede J Hofsteenge BA Hemmings, Biochemistry 1991 30 15 3589 3597 10.1021/bi00229a001 1849734
39. The protein kinase complement of the human genome. G Manning DB Whyte R Martinez T Hunter S Sudarsanam, Science 2002 298 5600 1912 1934 10.1126/science.1075762 12471243
40. cDNA cloning, chromosomal mapping, and expression analysis of human VE-Cadherin-2. D Ludwig J Lorenz E Dejana P Bohlen DJ Hicklin L Witte B Pytowski, Mamm Genome 2000 11 11 1030 1033 10.1007/s003350010186 11063261
41. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia. LA Fernandez EM Garrido-Martin F Sanz-Rodriguez M Pericacho A Rodriguez-Barbero N Eleno JM Lopez-Novoa A Duwell MA Vega C Bernabeu LM Botella, Hum Mol Genet 2007 16 13 1515 1533 10.1093/hmg/ddm069 17420163
42. Angiogenesis: the VE-cadherin switch. Y Wallez I Vilgrain P Huber, Trends Cardiovasc Med 2006 16 2 55 59 10.1016/j.tcm.2005.11.008 16473763
43. VE-cadherin is a critical endothelial regulator of TGF-beta signalling. N Rudini A Felici C Giampietro M Lampugnani M Corada K Swirsding M Garre S Liebner M Letarte P ten Dijke E Dejana, Embo J 2008 27 7 993 1004 10.1038/emboj.2008.46 18337748
44. Sprouty proteins: antagonists of endothelial cell signaling and more. MA Cabrita G Christofori, Thromb Haemost 2003 90 4 586 590 14515177
45. Inhibition of angiogenesis by a mouse sprouty protein. SH Lee DJ Schloss L Jarvis MA Krasnow JL Swain, J Biol Chem 2001 276 6 4128 4133 10.1074/jbc.M006922200 11053436
46. Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. K Taniguchi T Ayada K Ichiyama R Kohno Y Yonemitsu Y Minami A Kikuchi Y Maehara A Yoshimura, Biochem Biophys Res Commun 2007 352 4 896 902 10.1016/j.bbrc.2006.11.107 17156747
47. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. K Taniguchi T Ishizaki T Ayada Y Sugiyama Y Wakabayashi T Sekiya R Nakagawa A Yoshimura, Cancer Sci 2009 100 9 1648 1654 10.1111/j.1349-7006.2009. 01214.x 19493272
48. One-step enzymatic purification of PCR products for direct sequencing. JB Kim S Blackshaw, Curr Protoc Hum Genet 2001 Chapter 11 Unit 11 16 18428248
49. A rapid, inexpensive method for eluting DNA from agarose or acrylamide gel slices without using toxic or chaotropic materials. H Schwarz JL Whitton, Biotechniques 1992 13 2 205 206 1389152
50. Purification and concentration of DNA from aqueous solutions. D Moore, Curr Protoc Immunol 2001 Chapter 10 Unit 10 11
51. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. PJ Bray RG Cotton, Hum Mutat 2003 21 6 557 568 10.1002/humu.10213 12754700
52. Enhancement of PCR amplification yield and specificity using AmpliTaq Gold DNA polymerase. T Moretti B Koons B Budowle, Biotechniques 1998 25 4 716 722 9793657
53. Phusion™ Hot Start High-Fidelity DNA Polymerase (manual). http://www.neb.com/nebecomm/ManualFiles/manualF-540.pdf
54. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Q Chou M Russell DE Birch J Raymond W Bloch, Nucleic Acids Res 1992 20 7 1717 1723 10.1093/nar/20.7.1717 1579465
55. Regulation of endothelial cell gene expression: insights from HHT3 candidate gene studies. FS Govani, PhD thesis Imperial College London, NHLI Cardiovascular Sciences department 2009